Navigation Links
Pausing Hormone Therapy Doesn't Cut Mammogram Recalls
Date:6/3/2009

Repeat imaging rates similar whether women stopped hormone treatment or not, study finds

WEDNESDAY, June 3 (HealthDay News) -- Taking a break from hormone therapy before a mammogram doesn't lower the likelihood of being called back for extra imaging, a study including more than 1,700 women aged 45 to 80 has found.

"Postmenopausal hormones make breasts denser -- like young women's breasts -- and make mammograms harder to read," which increases the chance of a false-positive result, Diana S.M. Buist, an associate investigator at Group Health Center for Health Studies in Seattle, explained in a news release from the center.

A false-positive result means that after their initial mammogram, women are called back for more testing that reveals that they don't have breast cancer. Buist noted that false-positive results account for about 25 percent of overall costs of mammograms in the United States.

Previous research suggested that stopping hormone therapy could improve mammography results for postmenopausal women, but this new study, published in the June 2 issue of the Annals of Internal Medicine, found no evidence to support that theory.

Buist and colleagues found that 11.3 percent of women who stayed on hormone therapy before their mammogram were called back for more tests, compared with 12.3 percent and 9.8 percent, respectively, of women who stopped hormone therapy for one or two months before their mammogram.

"We really hoped to find that a brief break in hormone therapy would lower false-positives, and remove unnecessary costs and anxiety by improving mammography. And we're disappointed to find that it didn't," Buist said in the news release. "But we'll keep trying to find ways to reduce recall rates for women -- in hopes of making mammography more effective and ensuring women have to go through the least amount of testing and radiation that's necessary."

More information

The U.S. National Women's Health Information Center has more about mammograms.



-- Robert Preidt



SOURCE: Group Health Center for Health Studies, news release, June 1, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Drop in breast cancer incidence linked to hormone use, not mammograms
2. Researchers develop long-lasting growth hormone
3. One of the Largest Post-WHI Physician Surveys Shows More Education is Needed: Patient Misinformation About Hormone Therapy Remains High
4. Less than one-third of women aware of landmark hormone therapy study, Stanford researcher finds
5. Most Women Unaware of Hormone Replacement Study
6. Survival data presented from phase II study of hormone-resistant prostate cancer patients
7. Hormone May Play Key Part in Creating Memories
8. Hormone Therapy for Prostate Cancer Linked to Heart Risks
9. Wyeth to Appeal Nevada Hormone Therapy Trial Verdict
10. New data on hormone therapy must lead to re-evaluation of official guidelines
11. From Hot Flashes to Breast Cancer: ZRT Labs Hormone Testing Catches On As Women Consider Safer, More Natural Options.
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Pausing Hormone Therapy Doesn't Cut Mammogram Recalls
(Date:6/26/2016)... Charlotte, NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind ... able to be personalized through a fitness app. The fitness app plans to fix the ... solutions currently only offer a one size fits all type program , They ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... , , , WHEN: ... , , , , LOCATION: , , , Online, with ... , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice ... Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... industry is witnessing an exceptional era. Several new demand spaces, such ...
(Date:6/23/2016)... -- The vast majority of dialysis patients currently receive ... usually 3 times a week, with treatment times averaging ... equipment preparation and wait time.  This regimen can be ... who are elderly and frail.  Many elderly dialysis patients ... for some duration of time. Residents in ...
Breaking Medicine Technology: